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Abstract
Background: Using hybrid approach for gene selection and classification is common as results obtained are generally better
than performing the two tasks independently. Yet, for some microarray datasets, both classification accuracy and stability of
gene sets obtained still have rooms for improvement. This may be due to the presence of samples with wrong class labels
(i.e. outliers). Outlier detection algorithms proposed so far are either not suitable for microarray data, or only solve the
outlier detection problem on their own.
Results: We tackle the outlier detection problem based on a previously proposed Multiple-Filter-Multiple-Wrapper (MFMW)
model, which was demonstrated to yield promising results when compared to other hybrid approaches (Leung and Hung,
2010). To incorporate outlier detection and overcome limitations of the existing MFMW model, three new features are
introduced in our proposed MFMW-outlier approach: 1) an unbiased external Leave-One-Out Cross-Validation framework is
developed to replace internal cross-validation in the previous MFMW model; 2) wrongly labeled samples are identified
within the MFMW-outlier model; and 3) a stable set of genes is selected using an L1-norm SVM that removes any redundant
genes present. Six binary-class microarray datasets were tested. Comparing with outlier detection studies on the same
datasets, MFMW-outlier could detect all the outliers found in the original paper (for which the data was provided for
analysis), and the genes selected after outlier removal were proven to have biological relevance. We also compared MFMW-
outlier with PRAPIV (Zhang et al., 2006) based on same synthetic datasets. MFMW-outlier gave better average precision and
recall values on three different settings. Lastly, artificially flipped microarray datasets were created by removing our
detected outliers and flipping some of the remaining samples’ labels. Almost all the ‘wrong’ (artificially flipped) samples
were detected, suggesting that MFMW-outlier was sufficiently powerful to detect outliers in high-dimensional microarray
datasets.
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Introduction
Classification is one of the major goals in microarray data
analysis [1–7]. However, the quality of classifier depends critically
on the correct labelling of the training data [8]. There are chances
that some samples in a microarray data are given wrong class
labels (due to subjective labelling, imperfectness in experiments or
heterogeneity of data [9]. The presence of such mislabelled
samples, even a small number of them, could severely degrade the
performance of the classifier [8]. As reported in different studies
using an unbiased validation model, perfect leave-one-out cross-
validation (LOOCV) accuracies cannot be achieved in many
microarray datasets [10–11] even though many gene selection
tools have been combined with classifiers of different natures in
various experiments. This suggests something wrong about these
datasets which may be caused by the presence of wrongly labelled
samples. We call these samples ‘outliers’. Their existence can only
degrade the classification performance of any model. Previous
work has reported the adverse impact of mislabelled samples on
the performance of classification [8]. If no outlier detection and
removal process is done either prior to or in conjunction with gene
selection and classification, results obtained from the classification
task can be seriously affected by the presence of these outliers.
Consequently a promising outlier detection algorithm is essential
for the microarray data analysis process.
Gene selection is another major goal in microarray data
analysis; it is not only necessary for efficient classification, but also
important for biomarker identification [12–14]. For microarray
classification problems, evaluation on stability of gene sets is often
neglected. Concern has recently been expressed regarding the fact
that different studies reveal different gene sets for predicting the
prognosis of breast cancer [15–16]. It is crucial to check whether
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the selected gene sets are stable or not, as a concise and stable gene
set is easier to interpret. Besides, as the selected genes will be used
for prognosis, a small set of genes is much cheaper and easier to be
applied to large-scale dataset than long gene lists. The stability of
selected genes refers to whether the same set of genes is chosen
when perturbation of data occurs. Ideally, if only a small portion of
training samples in two datasets is different, the sets of genes
selected from these two datasets should not vary significantly. If
large variations in selected gene sets are observed, this signifies
something unusual among the samples in the data [17]. Note that
stability only indicates the sensitivity of the gene selection
algorithm with respect to perturbation of data, and does not
necessarily have a bearing on the performance of selected genes.
Various studies have proposed different ways of ‘stabilizing’ the
gene selection process [18–19]. As different sets of genes are
selected corresponding to different perturbations, the selected
genes can be ranked by their frequency of selection. A gene is most
certain to be relevant to the classification task if it is selected most
of the time. Gene set stability is often evaluated by LOOCV to see
how consistent the selected gene set is when different samples are
left out. It is possible that the selected gene sets are fairly stable,
except when the left-out sample is an outlier. This is because for all
training datasets containing the outlier, the outlier affects each of
these training datasets in a similar way resulting in a ‘stable and
consistent’ set of genes to be selected. But once the outlier is
removed from the training dataset, its influence is lost and so the
selected gene set may be quite different. Hence, it is crucial that
outliers be removed for gene stability to be taken as a useful
measure.
Outlier detection is a process to search for samples that do not
obey the general rules of the majority portion of the data of the
same class. Many outlier detection algorithms have been proposed,
yet most of them [20–22] attempt to detect outliers by computing
the distances in the full dimensional space. As microarray data is of
high dimensional space, and due to the sparse nature of distance
distributions, the concept of similarity may not be meaningful [20–
21]. Since outlier detection algorithms developed for other
domains are not suitable for microarray data, tailor-made outlier
detection methods for detecting wrong-labelled samples are
proposed. Furey et al. applied SVM on microarray datasets with
reduced set of genes. Samples which have been consistently
misclassified in all tests are identified as suspects [9]. Kadota et al.
proposed a method based on Akaike’s Information Criterion to
detect outliers in the colon data [23]. In the study conducted by Lu
et al., outliers are detected using support vector machine (SVM) in
a re-validation framework [24]. Zhang et al. introduced the
misclassification probability which is estimated for each sample in
the training set [25]. Unger and Chor developed a method for
finding all pairs of genes that induce a linear separation of the two
sample classes. If no gene pairs can separate the two classes
distinctly, then the dataset contains outliers [26]. In the study by
Malossini et al. [8], two algorithms are designed for detecting
possible mislabelled samples: a Classification-stability (CL-stability)
algorithm and a Leave-One-Out-Error-sensitivity (LOOE-sensi-
tivity) algorithm. The CL-stability algorithm evaluates the stability
of classification of a sample by perturbing a small amount of
samples, whereas LOOE-sensitivity is based on the idea that the
classification accuracy should be improved after flipping the label
of a mislabelled sample. In 2011, Zhou et al. modified the CL-
stability approach. Their goal was to detect outlier samples and
automatically correct them, and their proposed method was called
Fast Outlier Samples Detection (FOSD) [27].
The aims in all the above studies are to design an outlier
detection algorithm on their own. A distinctive feature of our
proposed MFMW-outlier framework is that outlier detection is
integrated within a proposed hybrid approach. This ‘three-in-one’
approach performs gene selection, classification and outlier
detection simultaneously, which is particularly suitable for high-
dimensional microarray datasets.
Materials and Methods
Datasets
Our aim was to identify any wrongly labelled samples present in
a high dimensionality data, such as microarray. Six benchmark
binary-class datasets on cancers were selected for evaluation using
the algorithm proposed. With the help of synthetic datasets, the
effectiveness of MFMW-outlier could be demonstrated despite the
absence of ground truth information for which samples are
outliers.
1.Microarray datasets. The six chosen binary-class datasets,
all generated using Affymetrix chips, were: LEU, COL, BRE,
LYM, PROS and LUNG. They were pre-processed according to
the instructions published in the original paper. In addition,
each sample was normalized to have mean zero and unit
variance. Table 1 summarizes the data we used.
2. Synthetic datasets. Synthetic datasets were more reliable as
the class labels for all samples were known. Experimental
results obtained from these datasets could therefore reflect the
true performance of the proposed algorithm. In a recent study
on detecting outliers in microarray data [25], artificial datasets
were generated as part of their experiments. The number and
characteristics of samples and features included in our synthetic
datasets were the same as theirs. Although microarray datasets
may have different characteristics, e.g. varied number of genes,
varied proportion of samples in each class or varied number of
classes, our main objective here is to compare MFMW-outlier
with the performance in [25] using the same datasets. Each of
our synthetic binary-class datasets contained 30 samples, with
equal number of samples in each class. Each of the samples was
given a class label of +1 or 21. A total of 10,000 features
(typical number of genes on microarray) were randomly
generated, of which 5 were discriminating ones created based
on Gaussian Distributions. m and s are the mean and standard
deviations of the discriminatory features. For class 1, m=23
and s= 1 while for class 2, m=23 and s= 3. The remaining
features were generated as Gaussian noise. A total of 3 different
synthetic datasets were created based on the above character-
istics. They differed only in the number of mislabeled samples
present: 4 (Test 1), 6 (Test 2) and 10 (Test 3). These
corresponded to Test 1–3 generated by Zhang et al. [25].
Table 2 summarizes the synthetic datasets we used.
Table 1. Summary of the six binary-class microarray datasets.
Dataset No. of samples No. of genes References
LEU 38 ALL, 34 AML 7129 [1]
COL 40 cancer, 22 normal 2000 [2]
BRE 25 ER+, 24 ER2 7129 [3]
LYM 58 DLBCL, 19 FL 7129 [4]
PROS 50 normal, 52 cancer 12000 [5]
LUNG 150 ADCA, 31 MPM 12600 [6]
doi:10.1371/journal.pone.0046700.t001
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Methods
Our proposed integrated MFMW-outlier approach is built on
top of the MFMW model proposed in [28]. However, to address
the limitations, we propose here three major modifications to
MFMW, and will refer to the new model as N-MFMW:
1. The optimal number of genes selected in the multiple-wrapper
step in MFMW-outlier is determined using an L1-norm SVM,
whereas those selected in earlier approach was based on a
threshold, i.e. a fixed number of genes.
2. The entire gene selection and classifier procedure of MFMW-
outlier is built within a fully unbiased LOOCV framework (i.e.
external LOOCV) in our present approach, as opposed to
applying LOOCV only to the classification part only in [28].
3. Identifying wrongly labelled samples is made possible through
the use of external LOOCV, as each sample is left out
completely from start, including the gene selection process.
Since the present approach is based on the MFMW model
developed in [28], in the following we only discuss the new features
introduced here beyond the framework already developed in [28].
We refer to this new model as N-MFMW. Interested readers are
referred to the paper [28] for more details on the original MFMW.
1. MFMW Model under External LOOCV. (This is a
modification of the original MFMW). Let S~ Sk Dk~1, . . . ,Kf g
be a dataset of samples. The N-MFMW model in an external
LOOCV framework is illustrated in Figure 1. LOOCV is
performed in the outermost loop (together with the boxes
highlighted in blue), whereby each sample Sk is left out in turn
before N-MFMW is applied to the training set Sk~S{ Skf g.
Note that all subsequent symbols with subscript k refer to data
generated after leaving out sample Sk.
Multiple-Filter part. The same three filters were used as in
MFMW. One hundred and fifty genes are selected by each filter
and the three gene lists are then combined by taking their union.
Multiple-Wrapper part. The same three wrappers were
used in MFMW. Please refer to [28] for details.
L1-SVM for incremental gene selection. (This is a
modification of the original MFMW) Suppose the set of samples
S are represented by points xi[Rd where each xi belongs to one of
two classes with label yi[ {1,1f gD. An SVM is constructed by
computing a classifier function f xð Þ~sgn wTxizbð Þ, where the
parameters w and b are determined by optimization:
min
w,b
wk k1zC
X
i
ji subject to yi Sxi,wTzbð Þ§1{ji,
ji§0, 1ƒiƒK
ð1Þ
The parameter C is a cost parameter and is provided as an input.
In the above optimization, we seek to minimize wk k1 instead of
the usual L2-norm wk k22 in traditional SVM. Minimizing wk k1
tends to give sparser solutions, which imply better dimension
reduction yielding classifiers of greater robustness [29].
In N-MFMW model, the number of genes selected at each level
of the wrapper part is ‘optimized’ using L1-SVM. Instead of taking
Table 2. Design of our synthetic datasets.
Dataset No. of samples No. of genes
No. of mislabeled
samples
Test 1 15 Class 1, 15 Class 2 10000 4
Test 2 15 Class 1, 15 Class 2 10000 6
Test 3 15 Class 1, 15 Class 2 10000 10
doi:10.1371/journal.pone.0046700.t002
Figure 1. N-MFMW model in an external LOOCV framework.
doi:10.1371/journal.pone.0046700.g001
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one/all gene(s) at the same level, the number of genes selected is
based on the wi scores outputted by the L1-SVM. The reason why
L1-SVM is chosen is due to its singularity nature. This nice
property allows the automatic selection of relevant genes with
respect to class labels of samples when there are several highly
correlated genes. The larger the wi score, the more informative
and less redundant the gene is, as compared to other genes of the
same level. A cut-off threshold is required for choosing a certain
number of genes. This is determined by finding the largest
difference between these wi values. By picking only a few genes
and removing the rest, L1-SVM selects a small subset of genes
from all the genes that have the same number of ‘W ’ and ‘I ’ [30].
Instead of selecting a pre-defined number of genes (as proposed in
[28,31]), the final number of selected genes is determined by wi
values in N-MFMW, which is data dependent.
External LOOCV and the final classification model. The
entire N-MFMW process is repeated for every sample Sk. At the
kth round of the LOOCV, after the incremental gene selection
process stops, we obtain the final gene set Pk and the
corresponding classification model Mk, which is composed of
the feature set Pk, the group of classifiers used as multiple
wrappers, and the voting scheme. The final model is trained again
using final gene set Pk and the sample set Sk to give the best
training accuracy. The trained model Mk is then used to test the
left-out sample Sk, yielding the test accuracy for Sk. Finally, the
LOOCV accuracy is computed as the percentage of correctly
classified test samples, and the gene stability measure Frequency
Of Occurrence (FOO) of a particular gene is calculated as the
number of times that gene is found on the list Pk k~1, . . . ,Kð Þ
outputted by the N-MFMW algorithm, divided by K .
2. Outlier Detection part. We now propose to incorporate
outlier detection into the N-MFMW model with external
LOOCV, as shown in Figure 2, which may be regarded as an
expansion of Figure 1 by introducing additional steps (highlighted
in blue) for outlier detection. As shown in Figure 2, a test sample
Sk is marked as an outlier if it is misclassified by all three classifiers
of the model Mk trained by N-MFMW based on Sk. This is a
highly convincing condition as it requires all classifiers, each based
on all samples other than the one under testing, to agree
unanimously that Sk ‘acts’ as if it has a label of the opposite
class. Such samples marked as outliers are removed only after one
complete cycle of LOOCV is performed. Since the removal of any
outlier(s) may have a significant impact on gene selection and
hence the N-MFMW training process, the entire LOOCV exercise
has to be repeated after outliers are removed.
Finally, the LOOCV accuracy and the gene stability measure
FOO can be computed based on a reduced dataset that has been
cleansed of outliers. The set of genes can then be ranked according
to their FOO scores from the largest to smallest, with a cut-off
threshold set for FOO values. The complete algorithm that
integrates all three components of gene selection, optimization of
classification accuracy and outlier detection, is given below.
MFMW-outlier – Outlier Detection under N-MFMW with
External LOOCV:
(1) Start with k~1.
(2) Define Training set Sk~S{ Skf g.
(3) Apply ‘Multiple Filters’ algorithm to Sk to get filtered gene list
Gk; apply ‘Multiple Wrappers’ algorithm to get gene set Pk
and train model Mk to give best accuracy for Sk. Record Pk
for computation of gene stability measure FOO.
(4) Apply Mk to test sample Sk; if the classification result is ‘W ’,
mark Sk as an outlier, otherwise the classification result is
recorded for computation of LOOCV accuracy.
(5) Repeat steps 2–4 for all Sk[S.
(6) If there are no samples marked as outliers, proceed to the next
step, otherwise remove all samples Sk marked as outliers from
S, update K~n Sð Þ, and repeat steps 1–5.
(7) Output:
(i) LOOCV accuracy based on test results for each Sk;
(ii) FOO of genes in P~UKk~1Pk;
(iii) Set of outlier samples.
The proposed MFMW-outlier is a significant modification of
the MFMW model proposed in [28,31] in that it represents a
‘three-in-one’ approach integrating all three components of gene
Figure 2. MFMW-outlier: Integrating outlier detection into N-
MFMW model with external LOOCV.
doi:10.1371/journal.pone.0046700.g002
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selection, classification and outlier detection in an unbiased
external LOOCV framework. Like MFMW, the underlying idea
of N-MFMW models is to first use multiple filters with
complementary characteristics to select genes, which are then
merged to provide a filtered subset of (several hundreds of) genes.
Different filters select genes with different statistical properties
across the classes under study. Therefore the use of multiple filters
of different natures ensures that potential biomarkers are unlikely
to be screened out by one specific filter criterion in an initial stage.
After gene screening by multiple filters, multiple wrappers are used
for incremental gene selection based on training accuracy. The use
of multiple wrappers, together with a unanimous voting scheme, is
for enhancing the robustness of the training accuracy by means of
consensus. Though one of the toughest issues for the wrapper
methods is computational complexity [32], our approach handles
this problem in two ways: 1) restricting the number of genes to be
included, largely by the use of multiple filters, which is in turn
determined by the number of genes picked up by each filter (in our
experiment we used 20); 2) choosing a simple classifier: e.g. k-NN
will perform much faster than neural network, genetic algorithms
or other classifiers that require optimization of lots of parameters.
An external LOOCV is then performed to evaluate the
performance of the classifier. More importantly, the use of
external LOOCV in the N-MFMW framework allows a natural
outlier detection and gene set stability evaluation. LOOCV is
chosen instead of other model estimation methods (like boot-
strapping) as a score can be assigned to each sample specifically for
the determination of whether it is an outlier or not. This score can
be easily obtained if only one sample is left out each time. When
multiple samples are left out (as in the case of bootstrapping or
other cross-validation tools), each time certain portions of samples
are used in testing, and the final score for outlier detection will be
dependent on the results from several runs. There are two
disadvantages of doing so: 1) including several samples together as
a test set will obscure the signal of an outlier (if any); 2) additional
steps are required to combine the scores from different runs.
Though cross validation should be normally performed to
evaluate the performance of a classifier, in previous microarray
studies, the most common misuse of validation involves selecting
genes using the full dataset, called internal cross-validation, rather
than performing gene selection from scratch within each loop of
the cross-validation [33]. MFMW was built upon this and this is
the major limitation [28,31]. Internal cross-validation may
favourably bias the performance of the classifier, as the training
and testing parts of the dataset are not independent of each other
[34]. Studies have shown that this may lead to very optimistic
estimates of the error rate [35–36]. To address this, we employ
external LOOCV in N-MFMW where gene selection is performed
without the benefit of knowledge of the test sample.
Results and Discussion
Results on six microarray datasets
We first applied MFMW-outlier on the six microarray datasets.
These selected datasets are the most ‘well-studied’ ones in the
microarray community. The first three datasets used in our
current study [8,25–27,37] have also been used in other newly
proposed outlier detection methodologies, and for comparison
purpose, they are included here. For most microarray datasets in
public domains, there is no available information as to which of
the samples might possibly be an outlier. The lack of ground truth
makes these less suitable for the present study.
Table 3 summarizes all the removed outliers in each iteration in
the external LOOCV. For five out of the six microarray datasets
we worked on, different number of outliers were removed in each
iteration. For LUNG data, no outlier was detected.
Comparison with other proposed outlier detection methodolo-
gies on microarray datasets were made [8,25–27,37]. For LEU
data, the only outlier being detected in every algorithm is Sample
66. Tables 4 and 5 compare the outlier detection results using
different methods on the other two datasets: COL and BRE.
Table 3. Sample(s) removed as outliers in each iteration of MFMW-outlier for all the six microarray datasets.
Dataset Iteration Samples left (#) Suspected outlier (sample ID)
LEU 1st 72 66
2nd 71 NIL
COL 1st 62 T33, T36, T37, N20
2nd 58 T2, T30
3rd 56 N2, N8, N18
4th 53 NIL
BRE 1st 49 Marks206, Marks213, Nevins24, Nevins26, Marks219,
Marks220
2nd 43 Marks204, Marks216, Nevins21
3rd 41 NIL
LYM 1st 77 DLBC26, FSCC12, FSCC13, FSCC16
2nd 73 DLBC29, DLBC36 and FSCC18
3rd 70 NIL
PROS 1st 102 N35_normal, N38_normal, T39_tumor, T49_tumor,
T54_tumor
2nd 97 N06_normal, T17_tumor, T37_tumor
3rd 94 NIL
LUNG 1st 181 NIL
doi:10.1371/journal.pone.0046700.t003
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In both Tables 4 and 5, MFMW-outlier was the only method
that can detect all the outliers (mislabelled samples) claimed in the
original paper (for which the datasets were provided for analyses).
This shows MFMW-outlier was the most consistent with the
‘ground truth’. For other methods, both false positives and false
negatives were found in both COL and BRE datasets.
At the end of MFMW-outlier, a set of stable genes was selected.
Table 6 shows the gene sets chosen for each of the six datasets.
Genes selected by MFMW-outlier were quite different from other
published results including our MFMW model [28]. This is due to
the fact genes in Table 6 were selected after all susceptible outliers
were removed, which means they are of better confidence as they
are not affected by the possible contaminations underlying the
samples. Also the genes selected here are from a fully unbiased
cross-validation model. Selected genes from Table 6 with
biological significances in the published literatures are discussed
as follows:
N LEU
N CST3 is related to AML [38].
N MGST3 was linked indirectly with GSTM1 according to
BioGraph [39]. Polymorphism in GSTM1 was shown to
have effect on the ALL patients. [40].
N By BioGraph [39], PSMB8 was indirect related to a number
of genes (PTPN1, BAD, PRAME, BIRC2, CFLAR and
MLL) causing AML and it was a gene target for a study
using high-throughput gene mutation analysis in AML [41].
N The relationship of MYB with acute leukemias has been
shown [42].
N COL
N VIP has been shown to regulate the growth of colonic
adenocaricinoma cells [43].
N BRE
N DSC3 expression was down-regulated in more than half of
breast cancers [44].
N ETV1, also known as ER81, was shown to be collaborated
with the oncoprotein HER2/Neu to activate Smad7
transcription in breast cancer cell lines [45].
N LYM
N Transgenic mice overexpressing HMGA1 gene was shown to
develop natural killer cell lymphomas [46] and by BioGraph
[39], HMGA1 was directly related to mir16-1, which is a
lymphoma causing miRNA [47].
N The updated annotation for JTV-1 is AIMP2 gene, which is
shown to have protein interaction with RARS gene, which
has direct relationship to mir16-1 by BioGraph [48].
N PROS
N HPN is a potentially important candidate gene involved in
prostate cancer susceptibility [49].
N NELL2 mRNA expression was predominantly localized in
basal cells of the epithelium in situ hybridization analysis of
hyperplastic prostate specimens [50]
N LUNG
N According to BioGraph [39], KLK3 is interacting with
PTHLH, which is a disease causing gene for non-small cell
lung carcinoma [51].
N By Biograph [39], PTRF is transcriptionally regulating
ERCC6 gene, which is a disease causing gene of lung
carcinoma [52].
N Similarly, SERPINH1 is interacting with CD9 gene, which is
a disease causing gene of non-small cell lung carcinoma [53].
Results on three synthetic datasets
Besides microarray datasets, MFMW-outlier was also evaluated
upon using three synthetic datasets (Tests 1–3 in Table 2). We
compared our results with PRAPIV [25]. To determine the ability
of detecting the outliers of the two algorithms, mean precision and
recall values were used for evaluation and were summarized in
Table 7. Precision is defined as the portion of true outliers in all
Table 4. List of outliers detected by different proposed
methods on COL.
Original
CL-
Stability PRAPIV FOSD
MFMW-
outlier
Sample
ID. [2] [8] [25] [27] NA
T2 Y Y - Y Y
T30 Y Y Y Y Y
T33 Y Y Y Y Y
T36 Y Y Y Y Y
T37 Y - Y Y Y
N8 Y - Y Y Y
N12 Y - - - Y
N34 Y Y Y Y Y
N36 Y Y Y Y Y
Others NA N2, N28 N2, N28 N2, N28 NA
doi:10.1371/journal.pone.0046700.t004
Table 5. List of outliers detected by different proposed
methods on BRE.
Original
CL-
Stability PRAPIV FOSD
MFMW-
outlier
Sample ID. [3] [8] [25] [27] NA
Nevins21 Y - - - Y
Nevins24 Y Y - Y Y
Nevins26 Y Y Y Y Y
Marks204 Y Y Y Y Y
Marks206 Y - - - Y
Marks213 Y - Y Y Y
Marks216 Y Y Y Y Y
Marks219 Y Y - Y Y
Marks220 Y - - - Y
Others NA 47 19 NA NA
doi:10.1371/journal.pone.0046700.t005
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the detected outliers, while recall is defined as the portion of
detected outliers in all the ground truth outliers.
Table 7 shows that MFMW-outlier gave much better precision
and recall values across all three synthetic datasets, demonstrating
the robustness of MFMW-outlier. Regardless of the number of
outliers present in the data, MFMW-outlier could detect almost all
of them.
Results on artificially flipped microarray datasets
It’s almost impossible to know which samples are wrongly
labelled in typical microarray datasets. According to microarray
studies on Colon cancer [2] and Breast cancer [3], the samples
under column ‘Original’ in Tables 4 and 5 were identified as
outliers with biological evidences. Similar to what Zhang et al. have
performed [25], these two datasets were selected for constructing
artificially flipped datasets. After removing the outliers under the
‘Original’ column, six samples were randomly selected from the
reduced dataset and their class labels were flipped. We then
applied MFMW-outlier to these datasets, with an aim to identify
these six samples. Experiments were performed on each dataset
(reduced-COL and reduced-BRE respectively) 50 times. We report
how accurate we were able to detect the six artificially labelled
samples, with comparison to PRAPIV [25], in terms of mean
precision and recall values as summarized in Table 8. The results
demonstrated that MFMW-outlier yielded much better precision
and recall values for both flipped datasets, as compared to
PRAPIV.
If an algorithm reports N outliers, denote p as precision and r as
recall, we expect that there are 1{pð ÞN false positives (FP) and
1
r{1
 
pN false negatives (FN). Assume that these mean precision
and recall obtained from flipped microarray datasets also apply to
the real microarray dataset, through simple calculation, for
MFMW-outlier there should be 0.28 FP and 0.15 FN in COL
and 0.41 FP and 0.50 FN in BRE, which corroborate with the
results shown in Tables 4 and 5, demonstrating that the excellent
result obtained for the two real datasets are highly reliable rather
than just by chance. As a comparison, for PRAPIV there should
be 2.56 FP and 0.91 FN in COL and 0.58 FP and 0.41 FN in BRE,
which is over optimistic when compared to the real values shown
in Tables 4 and 5, further demonstrating the superior robustness of
MFMW-outlier.
Effects of filters and wrappers on MFMW-outlier model
We are also interested in how classification performance
changes when different number of filters and wrappers are used
in our MFMW-outlier model. Consider varying the number of
filters in the model. If too few filters are used, inadequate genes of
dissimilar characteristics are selected. If too many filters are used,
some of the selected genes across the different gene lists are
redundant in nature. To investigate how many filters should be
included, we check if the biological significant genes discussed in
the previous session are all present in all gene lists produced by
different filters. The gene lists are obtained by setting n= 200 genes
for each filter. Table 9 below shows the presence (Y) or absence
(N) of each gene within the top ranked 200 genes selected by the
three filters we used.
The following conclusions can be drawn from results in Table 9:
N SNR and TS select almost the same set of genes, except for
CST3 in LEU, and hence if SNR is not included as one of the
filter, this gene would be missed out
N Similar for the case of NELL2 in PROS, and so TS is an
important filter.
N There are two genes: ETV1 in BRE and HMGA1 in LYM
which are only selected by AUC, but not by the other two
filters. This suggests that AUC is an important filter.
Next, we investigate if the number of wrappers (and if possible,
choice of wrappers) used in the MFMW-outlier model would result
in variations in the classification performance of the model. By the
basic idea of the multiple wrapper approach, there has to be more
than two wrappers. On the other hand, using too many wrappers
of similar nature does not provide more information for the
decision process. Therefore, the number of wrappers employed in
the following experiment varies from two to four. In addition to
the three wrappers we used, the extra wrapper chosen is Naı¨ve
Bayes (NB). This wrapper is selected because it is one of the most
Table 6. Final stable set of genes (gene symbols shown)
obtained from performing MFMW-outlier (after removal of
outliers) on six microarray datasets.
LEU COL BRE LYM PROS LUNG
CST3 VIP UBE3A HLA-A HPN KLK3
MGST3 GSTM4 DSC3 HMGA1 LMO3 PTRF
PSMB8 ETV1 JTV-1 NELL2 SERPINH1
MYB ENO1 MTHFD2
TCRB
doi:10.1371/journal.pone.0046700.t006
Table 7. Comparison of the mean precision and recall values on the synthetic datasets.
Test1 Test 2 Test 3
PRAPIV MFMW-outlier PRAPIV MFMW-outlier PRAPIV MFMW-outlier
Precision 83.41% 98.15% 76.44% 96.39% 54.84% 96.86%
Recall 91.50% 98.91% 83.33% 96.77% 59.00% 97.34%
doi:10.1371/journal.pone.0046700.t007
Table 8. Comparison of the mean precision and recall values
on flipped microarray datasets.
Reduced-COL Reduced-BRE
PRAPIV MFMW-outlier PRAPIV MFMW-outlier
Precision 71.61% 96.87% 88.44% 95.49%
Recall 87.65% 98.28% 91.46% 94.54%
doi:10.1371/journal.pone.0046700.t008
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popular classifiers used in microarray experiments. In each
experiment, 200 genes are first selected by each of the three
filters. Experiments with different number of wrappers are then
performed on the LYM dataset.
Using genes selected by three filters, Table 10 shows the
experimental results obtained from MFMW-outlier models
consisting of two wrappers. As four wrappers are available, there
are a total of 4C2 = 6 experiments. For each experiment, we select
the final gene sets with the smallest values of ‘W ’ and ‘I ’. Very
often there are multiple gene sets of this characteristic. These set(s)
of genes are then evaluated and biased LOOCV accuracies are
obtained. Only when the gene set gives a perfect LOOCV
accuracy is its result recorded in the table. ‘# of genes’ is the size of
gene set selected by each MFMW-outlier models. ‘# of subsets
giving perfect LOOCV accuracy’ is the number of gene sets that
output a perfect biased LOOCV accuracy. From Table 10, the
best sets of wrappers (of size two) are ‘WV+k-NN’, ‘WV+SVM’
and ‘WV+NB’. All three models use an equally small set of eight
genes for perfect LOOCV performance. Although the two models
‘k-NN+SVM’ and ‘k-NN+NB’ both select eight genes in the final
gene set, the variations in terms of selected genes are too large to
allow one to decide on which gene set should be chosen finally.
Therefore they are not selected as the best models.
Using genes selected by three filters, Table 11 shows the
experimental results obtained from MFMW-outlier models built
by three or four wrappers. There are altogether 4C3 = 4
experiments built using three wrappers. The best set of wrappers
of size three is ‘WV+k-NN+SVM’, which is the same as the one we
presented earlier. Also, MFMW-outlier models built by using four
wrappers are not as good as that built by using three wrappers.
Hence, for the LYM dataset, using three wrappers for the
MFMW-outlier is most appropriate. Similar results (details not
shown here) have been obtained for other datasets. Note that the
size of gene set selected using MFMW-outlier based on three
wrappers is six, which is smaller than that (i.e., eight) selected using
two wrappers. As a smaller set of genes is able to give the same
biased LOOCV accuracy, we would recommend using the three
wrappers ‘WV+k-NN+SVM’ in MFMW-outlier model.
Extension for multiclass datasets
The proposed method can be extended to the case of multiclass
setting involving datasets with more than two classes. The straight
forward way is to build a classification model for each class that
separates this particular class from the remaining classes. This is a
one-versus-all (OVA) classification approach. Another possibility is
to train the classification model for every pair of classes in the
multiclass dataset. This is a one-versus-one (OVO) classification
approach. The challenge for the latter method is that an outlier
detected in an OVO model may not be a true outlier, as it may be
a sample that belongs to a class other than the two classes used for
building the OVO model. We would therefore recommend
building MFMW-outlier in an OVA manner. Other than this,
integrating MFMW-outlier with other multiclass methods like
error-correcting-codes approach will require more efforts, as such
approaches require the design of codes for classification beyond
the usage of just binary-class classifiers.
Conclusions
The main contribution of this paper is to integrate outlier
detection into an existing hybrid model, while making two
significant modifications to the hybrid model to address issues
on optimal gene selection and the problem of bias in internal cross
validation. The new ‘three-in-one’ MFMW-outlier model can
handle gene selection, sample classification and outlier detection
simultaneously. MFMW-outlier was evaluated using both micro-
array and synthetic datasets. All results showed that we were able
to detect the outlying samples present in high dimensional data.
When comparing with ‘ground truth’ obtained from original
paper, we were able to detect all the mislabelled samples, whereas
other methods may result in some FP and FN. The fact that the
selected genes were biologically confirmed was a strong indication
that we have removed the wrong samples correctly.
Table 9. Presence or absence of biological significant genes
as selected by different filters (n = 200).
SNR TS AUC
LEU CST3 Y N Y
MGST3 Y Y Y
PSMB8 Y Y N
MYB Y Y Y
COL VIP Y Y Y
BRE DSC3 Y Y Y
ETV1 N N Y
LYM JTV-1 Y Y N
HMGA1 N N Y
PROS HPN Y Y Y
NELL2 N Y Y
LUNG KLK3 Y Y Y
PTRF Y Y Y
SERPINH1 Y Y Y
doi:10.1371/journal.pone.0046700.t009
Table 10. MFMW-outlier results obtained from using three
filters (n = 200) and two wrappers for LYM dataset.
Wrappers # of genes # of subsets
WV+k-NN 8 1
WV+SVM 8 1
WV+NB 8 2
k-NN+SVM 8 20
k-NN+NB 8 18
SVM+NB 6 0
doi:10.1371/journal.pone.0046700.t010
Table 11. MFMW-outlier results obtained from using three
filters (n = 200) and three/four wrappers for LYM dataset.
Wrappers # of genes # of subsets
WV+k-NN+SVM 6 1
WV+k-NN+NB 6 2
WV+SVM+NB 6 4
k-NN+SVM+NV 6 2
WV+k-NN+SVM+NB 8 3
doi:10.1371/journal.pone.0046700.t011
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To conclude, we have demonstrated the feasibility of integrating
outlier detection into a hybrid model. The model is shown to have
very high robustness with respect to the number of outliers in the
dataset. We have implemented the proposed algorithm in
MATLABH and the software is available at http://people.pcbi.
upenn.edu/,yyee/MFMW-outlier/.
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